Contribution of sonographic measurement of ovarian volume to diagnosing ovarian tumors in postmenopausal women

@article{Bruchim2004ContributionOS,
  title={Contribution of sonographic measurement of ovarian volume to diagnosing ovarian tumors in postmenopausal women},
  author={Ilan Bruchim and Rami Aviram and Rivka Halevy and Yoram Beyth and Ronnie Tepper},
  journal={Journal of Clinical Ultrasound},
  year={2004},
  volume={32}
}
The purpose of this review article is to evaluate the current method of sonographic measurement of ovarian volume as a means of diagnosing ovarian tumors in postmenopausal women, in whom an ovarian volume greater than 10 ml is generally considered abnormal. After reviewing the general medical literature, we propose a nomogram of ovarian volume that may be used to determine whether an ovary is abnormal. Furthermore, on the basis of our previous results, we recommend that a cutoff point for… 
View on Wiley
ncbi.nlm.nih.gov
2 Citations
Methods Citations
1

2 Citations

Magnetic resonance imaging appearance of ovarian stromal hyperplasia and ovarian hyperthecosis.

The first published cases of the magnetic resonance imaging appearance of ovarian stromal hyperplasia and ovarian hyperthecosis are presented, which may mimic that of ovarian neoplasm.

Volumes of normal ovaries, ovaries with benign lesions, and ovaries with cancer in menopausal women: Is there an optimal cut‐off value to predict malignancy?

To evaluate different ovarian volume cut‐off values to distinguish between normal ovaries, benign lesions, and malignant lesions in menopausal women, a large number of studies have used the Heterogeneity Index, a proxy for ovarian volume, to measure ovarian volume in women.

References

SHOWING 1-10 OF 30 REFERENCES

A Comparison Between Ultrasound and Gynecologic Examination for Detection of Enlarged Ovaries in a Group of Women at Risk for Ovarian Carcinoma

  • S. GranbergM. Wikland
  • Medicine
    Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
  • 1988
A group of 115 women all relatives to women with ovarian carcinoma, were examined and no carcinoma was found, indicating that ultrasound examination of the ovaries is a much more reliable method for examining the ovary than gynecologic palpation.

Ovarian size in postmenopausal women

Factors associated with gonadal size have been identified, and reference ranges for derived indices have been determined for use (in association with criteria for abnormal morphology) in a screening programme for ovarian carcinoma.

REAL-TIME ULTRASONOGRAPHY FOR DETERMINATION OF OVARIAN MORPHOLOGY AND VOLUME A Possible Early Screening Test for Ovarian Cancer?

Comparison of Serum CA 125, Clinical Impression, and Ultrasound in the Preoperative Evaluation of Ovarian Masses

Measurement of serum CA 125 significantly increased diagnostic accuracy in postmenopausal patients and may thus have an important role in the preoperative evaluation of women with ovarian masses.

Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography

A multi‐institutional trial to determine the efficacy of TVS as a screening method for ovarian cancer is indicated.

Transvaginal sonography as a screening method for ovarian cancer

The use of transvaginal sonography for evaluation of postmenopausal ovarian size and morphology.

The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.

TVS screening does not appear to be effective in detecting ovarian cancer in which ovarian volume is normal, and when performed annually, is associated with a decreases in stage at detection and a decrease in case-specific ovarian cancer mortality.

Ovarian Cancer Screening in Asymptomatic Postmenopausal Women

A multi-institutional trial to test the efficacy of TVS as a screening method for ovarian cancer is indicated because of a decrease in stage at detection and case-specific mortality from ovarian cancer.

Transvaginal sonography as a screening method for the detection of early ovarian cancer